Sonal Paul, MD is a medical oncologist and hematologist with a strong background in clinical research and patient education. Her clinical interests include the treatment of gastrointestinal tract cancers, such as cancers of the esophagus, stomach, liver, colon, and rectum.

Dr. Paul is actively involved in research projects as the principal investigator for multiple clinical trials focusing on gastrointestinal therapeutics. These trials aim to advance the understanding and treatment of gastrointestinal cancers. She has written research articles on a variety of topics, including the role of immune checkpoint inhibitors in gastrointestinal malignancies, the genomic landscape of SMARCA4 alterations in lung cancer patients, and the efficacy of convalescent plasma in hospitalized COVID-19 patients.

Dr. Paul pursued her undergraduate education at the University of Maryland Baltimore County, where she earned a Bachelor of Science degree in Biological Sciences with a Minor in Psychology. She then attended Ross University School of Medicine, graduating with honors. Following medical school, Dr. Paul completed her Internal Medicine residency at New York Presbyterian Brooklyn Methodist Hospital – Weill Cornell Medicine. During her residency, she received additional training at the Memorial Sloan Kettering Cancer Center in New York. Subsequently, she pursued a fellowship in Hematology and Oncology at New York Presbyterian Brooklyn Methodist Hospital – Weill Cornell Medicine, where she also served as the Chief Fellow.

Dr. Paul is deeply committed to enhancing oncology care through personalized cancer treatment and patient education. Her dedication to tailoring treatment plans and empowering patients with knowledge underscores her mission to improve outcomes and foster a sense of empowerment in those she cares for. Through her multifaceted approach, Dr. Paul continues to make significant strides in advancing oncology care, ensuring that each patient receives the highest standard of personalized treatment and support.